Table I displays demographic, disease and treatment information for the whole cohort based on androgen ablation. Table II displays the characteristics of the EBRT and no-EBRT subgroups.

Background: Androgen ablation is often used in addition to low-dose-rate brachytherapy in the treatment of prostate cancer, particularly for disease with adverse features. We report a single ...

Journal of Clinical Oncology: “Quality of Life During Treatment With Chemohormonal Therapy: Analysis of E3805 Chemohormonal Androgen Ablation Randomized Trial in Prostate Cancer.” Health and ...

Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor ... factor receptor-2 blockade, hormone ablation, and chemotherapy.

Patients with metastatic prostate cancer may have improved survival outcomes after undergoing next-generation PSMA PET ...

Ablation therapy consists of a minimally invasive treatment, which can be used for treating cancer by destroying tumors and other abnormal tissues within the body. It uses either extremely high or ...

A study led by researchers from the UCLA Health Jonsson Comprehensive Cancer Center sheds light on testosterone recovery following androgen deprivation therapy (ADT) in men undergoing radiotherapy ...

Pulsed-field ablation (PFA) with a system encompassing the Varipulse catheter and Trupulse generator with integrated 3D electroanatomic mapping (all Biosense Webster) safely and effectively treats ...

Extended lymphadenectomy did not improve disease-free or overall survival compared to standard lymphadenectomy in muscle-invasive bladder cancer patients. Higher perioperative morbidity and mortality ...